Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00197808
Status:
COMPLETED
Last Update Posted:
2020-10-01
First Post:
2005-09-12
Brief Title:
Response of United Kingdom UK Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines
Sponsor:
Public Health England
Organization:
Public Health England
Study Overview
Official Title:
Response of United Kingdom UK Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines
Status:
COMPLETED
Status Verified Date:
2018-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
sched1
Brief Summary:
The purpose of the study is to evaluate the immune responses of UK infants after one or two doses of pneumococcal conjugate vaccine or one or two doses of three different types of meningococcal conjugate vaccine given at either two and three or two and four months of age
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None